nodes	percent_of_prediction	percent_of_DWPC	metapath
Mupirocin—IARS—mammary gland—breast cancer	0.0434	0.171	CbGeAlD
Mupirocin—IARS—embryo—breast cancer	0.0296	0.117	CbGeAlD
Mupirocin—IARS—epithelium—breast cancer	0.0241	0.0951	CbGeAlD
Mupirocin—IARS—skin of body—breast cancer	0.023	0.0905	CbGeAlD
Mupirocin—IARS—uterus—breast cancer	0.02	0.0786	CbGeAlD
Mupirocin—IARS—adipose tissue—breast cancer	0.0195	0.0769	CbGeAlD
Mupirocin—IARS—female reproductive system—breast cancer	0.0179	0.0706	CbGeAlD
Mupirocin—IARS—adrenal gland—breast cancer	0.0175	0.0689	CbGeAlD
Mupirocin—IARS—bone marrow—breast cancer	0.0169	0.0667	CbGeAlD
Mupirocin—IARS—female gonad—breast cancer	0.0163	0.0643	CbGeAlD
Mupirocin—IARS—endocrine gland—breast cancer	0.0152	0.0598	CbGeAlD
Mupirocin—IARS—lymph node—breast cancer	0.0105	0.0413	CbGeAlD
Mupirocin—Urticaria—Goserelin—breast cancer	0.000959	0.00129	CcSEcCtD
Mupirocin—Hypersensitivity—Vinblastine—breast cancer	0.000959	0.00129	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Methotrexate—breast cancer	0.000958	0.00128	CcSEcCtD
Mupirocin—Abdominal pain—Goserelin—breast cancer	0.000955	0.00128	CcSEcCtD
Mupirocin—Cough—Irinotecan—breast cancer	0.000954	0.00128	CcSEcCtD
Mupirocin—Cough—Mitoxantrone—breast cancer	0.000954	0.00128	CcSEcCtD
Mupirocin—Eczema—Epirubicin—breast cancer	0.000942	0.00126	CcSEcCtD
Mupirocin—Hypersensitivity—Tamoxifen—breast cancer	0.000932	0.00125	CcSEcCtD
Mupirocin—Cough—Gemcitabine—breast cancer	0.000929	0.00125	CcSEcCtD
Mupirocin—Pain—Vinorelbine—breast cancer	0.000925	0.00124	CcSEcCtD
Mupirocin—Immune system disorder—Paclitaxel—breast cancer	0.000925	0.00124	CcSEcCtD
Mupirocin—Hypersensitivity—Melphalan—breast cancer	0.000912	0.00122	CcSEcCtD
Mupirocin—Epistaxis—Docetaxel—breast cancer	0.000912	0.00122	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.0009	0.00121	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Epirubicin—breast cancer	0.000897	0.0012	CcSEcCtD
Mupirocin—Pruritus—Tamoxifen—breast cancer	0.000895	0.0012	CcSEcCtD
Mupirocin—Anaphylactic shock—Mitoxantrone—breast cancer	0.000892	0.0012	CcSEcCtD
Mupirocin—Anaphylactic shock—Irinotecan—breast cancer	0.000892	0.0012	CcSEcCtD
Mupirocin—Erythema—Paclitaxel—breast cancer	0.000891	0.00119	CcSEcCtD
Mupirocin—Diarrhoea—Vinblastine—breast cancer	0.00089	0.00119	CcSEcCtD
Mupirocin—Hypersensitivity—Goserelin—breast cancer	0.00089	0.00119	CcSEcCtD
Mupirocin—Gastrointestinal pain—Vinorelbine—breast cancer	0.000884	0.00119	CcSEcCtD
Mupirocin—Pain—Thiotepa—breast cancer	0.000883	0.00118	CcSEcCtD
Mupirocin—Epistaxis—Capecitabine—breast cancer	0.000883	0.00118	CcSEcCtD
Mupirocin—Pruritus—Melphalan—breast cancer	0.000876	0.00117	CcSEcCtD
Mupirocin—Dysgeusia—Paclitaxel—breast cancer	0.000873	0.00117	CcSEcCtD
Mupirocin—Haemoglobin—Docetaxel—breast cancer	0.000872	0.00117	CcSEcCtD
Mupirocin—Eczema—Doxorubicin—breast cancer	0.000871	0.00117	CcSEcCtD
Mupirocin—Rhinitis—Docetaxel—breast cancer	0.00087	0.00117	CcSEcCtD
Mupirocin—Anaphylactic shock—Gemcitabine—breast cancer	0.000869	0.00116	CcSEcCtD
Mupirocin—Haemorrhage—Docetaxel—breast cancer	0.000868	0.00116	CcSEcCtD
Mupirocin—Skin disorder—Mitoxantrone—breast cancer	0.000866	0.00116	CcSEcCtD
Mupirocin—Diarrhoea—Tamoxifen—breast cancer	0.000865	0.00116	CcSEcCtD
Mupirocin—Pharyngitis—Docetaxel—breast cancer	0.000861	0.00115	CcSEcCtD
Mupirocin—Dizziness—Vinblastine—breast cancer	0.000861	0.00115	CcSEcCtD
Mupirocin—Urticaria—Vinorelbine—breast cancer	0.000859	0.00115	CcSEcCtD
Mupirocin—Abdominal pain—Vinorelbine—breast cancer	0.000855	0.00115	CcSEcCtD
Mupirocin—Pruritus—Goserelin—breast cancer	0.000854	0.00115	CcSEcCtD
Mupirocin—Anaphylactic shock—Fluorouracil—breast cancer	0.000854	0.00115	CcSEcCtD
Mupirocin—Diarrhoea—Melphalan—breast cancer	0.000847	0.00114	CcSEcCtD
Mupirocin—Gastrointestinal pain—Thiotepa—breast cancer	0.000845	0.00113	CcSEcCtD
Mupirocin—Haemoglobin—Capecitabine—breast cancer	0.000845	0.00113	CcSEcCtD
Mupirocin—Skin disorder—Gemcitabine—breast cancer	0.000844	0.00113	CcSEcCtD
Mupirocin—Nausea—Chlorambucil—breast cancer	0.000844	0.00113	CcSEcCtD
Mupirocin—Rhinitis—Capecitabine—breast cancer	0.000842	0.00113	CcSEcCtD
Mupirocin—Haemorrhage—Capecitabine—breast cancer	0.00084	0.00113	CcSEcCtD
Mupirocin—Dizziness—Tamoxifen—breast cancer	0.000836	0.00112	CcSEcCtD
Mupirocin—Pharyngitis—Capecitabine—breast cancer	0.000834	0.00112	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Doxorubicin—breast cancer	0.00083	0.00111	CcSEcCtD
Mupirocin—Diarrhoea—Goserelin—breast cancer	0.000826	0.00111	CcSEcCtD
Mupirocin—Urticaria—Thiotepa—breast cancer	0.000821	0.0011	CcSEcCtD
Mupirocin—Abdominal pain—Thiotepa—breast cancer	0.000817	0.00109	CcSEcCtD
Mupirocin—Headache—Vinblastine—breast cancer	0.000815	0.00109	CcSEcCtD
Mupirocin—Angioedema—Paclitaxel—breast cancer	0.000814	0.00109	CcSEcCtD
Mupirocin—Dizziness—Goserelin—breast cancer	0.000799	0.00107	CcSEcCtD
Mupirocin—Rash—Tamoxifen—breast cancer	0.000797	0.00107	CcSEcCtD
Mupirocin—Hypersensitivity—Vinorelbine—breast cancer	0.000797	0.00107	CcSEcCtD
Mupirocin—Dermatitis—Tamoxifen—breast cancer	0.000796	0.00107	CcSEcCtD
Mupirocin—Headache—Tamoxifen—breast cancer	0.000792	0.00106	CcSEcCtD
Mupirocin—Immune system disorder—Docetaxel—breast cancer	0.000784	0.00105	CcSEcCtD
Mupirocin—Rash—Melphalan—breast cancer	0.000781	0.00105	CcSEcCtD
Mupirocin—Dermatitis—Melphalan—breast cancer	0.00078	0.00105	CcSEcCtD
Mupirocin—Cough—Paclitaxel—breast cancer	0.000778	0.00104	CcSEcCtD
Mupirocin—Dry skin—Epirubicin—breast cancer	0.000776	0.00104	CcSEcCtD
Mupirocin—Nausea—Vinblastine—breast cancer	0.000773	0.00104	CcSEcCtD
Mupirocin—Pruritus—Vinorelbine—breast cancer	0.000765	0.00103	CcSEcCtD
Mupirocin—Pain—Mitoxantrone—breast cancer	0.000763	0.00102	CcSEcCtD
Mupirocin—Pain—Irinotecan—breast cancer	0.000763	0.00102	CcSEcCtD
Mupirocin—Rash—Goserelin—breast cancer	0.000761	0.00102	CcSEcCtD
Mupirocin—Hypersensitivity—Thiotepa—breast cancer	0.000761	0.00102	CcSEcCtD
Mupirocin—Dermatitis—Goserelin—breast cancer	0.000761	0.00102	CcSEcCtD
Mupirocin—Immune system disorder—Capecitabine—breast cancer	0.000759	0.00102	CcSEcCtD
Mupirocin—Headache—Goserelin—breast cancer	0.000757	0.00101	CcSEcCtD
Mupirocin—Erythema—Docetaxel—breast cancer	0.000756	0.00101	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000754	0.00101	CcSEcCtD
Mupirocin—Nausea—Tamoxifen—breast cancer	0.000751	0.00101	CcSEcCtD
Mupirocin—Pain—Gemcitabine—breast cancer	0.000743	0.000996	CcSEcCtD
Mupirocin—Dry mouth—Paclitaxel—breast cancer	0.000742	0.000995	CcSEcCtD
Mupirocin—Diarrhoea—Vinorelbine—breast cancer	0.00074	0.000992	CcSEcCtD
Mupirocin—Dysgeusia—Docetaxel—breast cancer	0.00074	0.000992	CcSEcCtD
Mupirocin—Nausea—Melphalan—breast cancer	0.000735	0.000986	CcSEcCtD
Mupirocin—Erythema—Capecitabine—breast cancer	0.000731	0.00098	CcSEcCtD
Mupirocin—Pruritus—Thiotepa—breast cancer	0.000731	0.000979	CcSEcCtD
Mupirocin—Pain—Fluorouracil—breast cancer	0.000731	0.000979	CcSEcCtD
Mupirocin—Gastrointestinal pain—Irinotecan—breast cancer	0.000729	0.000978	CcSEcCtD
Mupirocin—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000729	0.000978	CcSEcCtD
Mupirocin—Anaphylactic shock—Paclitaxel—breast cancer	0.000727	0.000975	CcSEcCtD
Mupirocin—Dry skin—Doxorubicin—breast cancer	0.000718	0.000962	CcSEcCtD
Mupirocin—Nausea—Goserelin—breast cancer	0.000717	0.000961	CcSEcCtD
Mupirocin—Dysgeusia—Capecitabine—breast cancer	0.000716	0.00096	CcSEcCtD
Mupirocin—Dizziness—Vinorelbine—breast cancer	0.000715	0.000959	CcSEcCtD
Mupirocin—Urticaria—Mitoxantrone—breast cancer	0.000709	0.00095	CcSEcCtD
Mupirocin—Diarrhoea—Thiotepa—breast cancer	0.000707	0.000947	CcSEcCtD
Mupirocin—Skin disorder—Paclitaxel—breast cancer	0.000707	0.000947	CcSEcCtD
Mupirocin—Abdominal pain—Irinotecan—breast cancer	0.000705	0.000945	CcSEcCtD
Mupirocin—Abdominal pain—Mitoxantrone—breast cancer	0.000705	0.000945	CcSEcCtD
Mupirocin—Dizziness—Thiotepa—breast cancer	0.000683	0.000916	CcSEcCtD
Mupirocin—Rash—Vinorelbine—breast cancer	0.000682	0.000914	CcSEcCtD
Mupirocin—Dermatitis—Vinorelbine—breast cancer	0.000681	0.000913	CcSEcCtD
Mupirocin—Urticaria—Fluorouracil—breast cancer	0.000679	0.00091	CcSEcCtD
Mupirocin—Headache—Vinorelbine—breast cancer	0.000678	0.000908	CcSEcCtD
Mupirocin—Cough—Docetaxel—breast cancer	0.000659	0.000884	CcSEcCtD
Mupirocin—Epistaxis—Methotrexate—breast cancer	0.000657	0.000881	CcSEcCtD
Mupirocin—Hypersensitivity—Mitoxantrone—breast cancer	0.000657	0.000881	CcSEcCtD
Mupirocin—Hypersensitivity—Irinotecan—breast cancer	0.000657	0.000881	CcSEcCtD
Mupirocin—Rash—Thiotepa—breast cancer	0.000651	0.000873	CcSEcCtD
Mupirocin—Dermatitis—Thiotepa—breast cancer	0.000651	0.000872	CcSEcCtD
Mupirocin—Headache—Thiotepa—breast cancer	0.000647	0.000867	CcSEcCtD
Mupirocin—Nausea—Vinorelbine—breast cancer	0.000642	0.000861	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000639	0.000856	CcSEcCtD
Mupirocin—Cough—Capecitabine—breast cancer	0.000638	0.000856	CcSEcCtD
Mupirocin—Hypersensitivity—Fluorouracil—breast cancer	0.000629	0.000844	CcSEcCtD
Mupirocin—Dry mouth—Docetaxel—breast cancer	0.000629	0.000843	CcSEcCtD
Mupirocin—Haemoglobin—Methotrexate—breast cancer	0.000629	0.000843	CcSEcCtD
Mupirocin—Haemorrhage—Methotrexate—breast cancer	0.000626	0.000838	CcSEcCtD
Mupirocin—Pain—Paclitaxel—breast cancer	0.000622	0.000834	CcSEcCtD
Mupirocin—Pharyngitis—Methotrexate—breast cancer	0.000621	0.000832	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000618	0.000829	CcSEcCtD
Mupirocin—Anaphylactic shock—Docetaxel—breast cancer	0.000617	0.000826	CcSEcCtD
Mupirocin—Epistaxis—Epirubicin—breast cancer	0.000615	0.000824	CcSEcCtD
Mupirocin—Pruritus—Gemcitabine—breast cancer	0.000615	0.000824	CcSEcCtD
Mupirocin—Nausea—Thiotepa—breast cancer	0.000614	0.000822	CcSEcCtD
Mupirocin—Diarrhoea—Irinotecan—breast cancer	0.00061	0.000818	CcSEcCtD
Mupirocin—Diarrhoea—Mitoxantrone—breast cancer	0.00061	0.000818	CcSEcCtD
Mupirocin—Dry mouth—Capecitabine—breast cancer	0.000609	0.000816	CcSEcCtD
Mupirocin—Pruritus—Fluorouracil—breast cancer	0.000604	0.00081	CcSEcCtD
Mupirocin—Skin disorder—Docetaxel—breast cancer	0.000599	0.000803	CcSEcCtD
Mupirocin—Gastrointestinal pain—Paclitaxel—breast cancer	0.000595	0.000797	CcSEcCtD
Mupirocin—Diarrhoea—Gemcitabine—breast cancer	0.000595	0.000797	CcSEcCtD
Mupirocin—Dizziness—Irinotecan—breast cancer	0.00059	0.000791	CcSEcCtD
Mupirocin—Haemoglobin—Epirubicin—breast cancer	0.000588	0.000789	CcSEcCtD
Mupirocin—Rhinitis—Epirubicin—breast cancer	0.000587	0.000787	CcSEcCtD
Mupirocin—Haemorrhage—Epirubicin—breast cancer	0.000585	0.000785	CcSEcCtD
Mupirocin—Diarrhoea—Fluorouracil—breast cancer	0.000585	0.000783	CcSEcCtD
Mupirocin—Pharyngitis—Epirubicin—breast cancer	0.000581	0.000779	CcSEcCtD
Mupirocin—Skin disorder—Capecitabine—breast cancer	0.00058	0.000777	CcSEcCtD
Mupirocin—Urticaria—Paclitaxel—breast cancer	0.000578	0.000775	CcSEcCtD
Mupirocin—Abdominal pain—Paclitaxel—breast cancer	0.000575	0.000771	CcSEcCtD
Mupirocin—Epistaxis—Doxorubicin—breast cancer	0.000569	0.000763	CcSEcCtD
Mupirocin—Immune system disorder—Methotrexate—breast cancer	0.000565	0.000757	CcSEcCtD
Mupirocin—Dizziness—Fluorouracil—breast cancer	0.000565	0.000757	CcSEcCtD
Mupirocin—Rash—Mitoxantrone—breast cancer	0.000562	0.000754	CcSEcCtD
Mupirocin—Rash—Irinotecan—breast cancer	0.000562	0.000754	CcSEcCtD
Mupirocin—Dermatitis—Mitoxantrone—breast cancer	0.000562	0.000753	CcSEcCtD
Mupirocin—Dermatitis—Irinotecan—breast cancer	0.000562	0.000753	CcSEcCtD
Mupirocin—Headache—Mitoxantrone—breast cancer	0.000559	0.000749	CcSEcCtD
Mupirocin—Headache—Irinotecan—breast cancer	0.000559	0.000749	CcSEcCtD
Mupirocin—Rash—Gemcitabine—breast cancer	0.000548	0.000734	CcSEcCtD
Mupirocin—Dermatitis—Gemcitabine—breast cancer	0.000547	0.000734	CcSEcCtD
Mupirocin—Erythema—Methotrexate—breast cancer	0.000545	0.00073	CcSEcCtD
Mupirocin—Haemoglobin—Doxorubicin—breast cancer	0.000544	0.00073	CcSEcCtD
Mupirocin—Headache—Gemcitabine—breast cancer	0.000544	0.00073	CcSEcCtD
Mupirocin—Rhinitis—Doxorubicin—breast cancer	0.000543	0.000728	CcSEcCtD
Mupirocin—Haemorrhage—Doxorubicin—breast cancer	0.000542	0.000726	CcSEcCtD
Mupirocin—Rash—Fluorouracil—breast cancer	0.000539	0.000722	CcSEcCtD
Mupirocin—Dermatitis—Fluorouracil—breast cancer	0.000538	0.000721	CcSEcCtD
Mupirocin—Pharyngitis—Doxorubicin—breast cancer	0.000538	0.000721	CcSEcCtD
Mupirocin—Hypersensitivity—Paclitaxel—breast cancer	0.000536	0.000718	CcSEcCtD
Mupirocin—Headache—Fluorouracil—breast cancer	0.000535	0.000717	CcSEcCtD
Mupirocin—Dysgeusia—Methotrexate—breast cancer	0.000533	0.000715	CcSEcCtD
Mupirocin—Nausea—Mitoxantrone—breast cancer	0.00053	0.00071	CcSEcCtD
Mupirocin—Nausea—Irinotecan—breast cancer	0.00053	0.00071	CcSEcCtD
Mupirocin—Immune system disorder—Epirubicin—breast cancer	0.000529	0.000709	CcSEcCtD
Mupirocin—Pain—Docetaxel—breast cancer	0.000527	0.000707	CcSEcCtD
Mupirocin—Nausea—Gemcitabine—breast cancer	0.000516	0.000692	CcSEcCtD
Mupirocin—Pruritus—Paclitaxel—breast cancer	0.000515	0.00069	CcSEcCtD
Mupirocin—Pain—Capecitabine—breast cancer	0.000511	0.000684	CcSEcCtD
Mupirocin—Erythema—Epirubicin—breast cancer	0.00051	0.000683	CcSEcCtD
Mupirocin—Nausea—Fluorouracil—breast cancer	0.000507	0.00068	CcSEcCtD
Mupirocin—Gastrointestinal pain—Docetaxel—breast cancer	0.000504	0.000676	CcSEcCtD
Mupirocin—Dysgeusia—Epirubicin—breast cancer	0.000499	0.000669	CcSEcCtD
Mupirocin—Diarrhoea—Paclitaxel—breast cancer	0.000498	0.000667	CcSEcCtD
Mupirocin—Immune system disorder—Doxorubicin—breast cancer	0.000489	0.000656	CcSEcCtD
Mupirocin—Gastrointestinal pain—Capecitabine—breast cancer	0.000488	0.000654	CcSEcCtD
Mupirocin—Abdominal pain—Docetaxel—breast cancer	0.000487	0.000653	CcSEcCtD
Mupirocin—Dizziness—Paclitaxel—breast cancer	0.000481	0.000645	CcSEcCtD
Mupirocin—Cough—Methotrexate—breast cancer	0.000475	0.000637	CcSEcCtD
Mupirocin—Urticaria—Capecitabine—breast cancer	0.000474	0.000636	CcSEcCtD
Mupirocin—Abdominal pain—Capecitabine—breast cancer	0.000472	0.000633	CcSEcCtD
Mupirocin—Erythema—Doxorubicin—breast cancer	0.000472	0.000632	CcSEcCtD
Mupirocin—Dysgeusia—Doxorubicin—breast cancer	0.000462	0.000619	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.00046	0.000617	CcSEcCtD
Mupirocin—Rash—Paclitaxel—breast cancer	0.000459	0.000615	CcSEcCtD
Mupirocin—Dermatitis—Paclitaxel—breast cancer	0.000458	0.000614	CcSEcCtD
Mupirocin—Headache—Paclitaxel—breast cancer	0.000456	0.000611	CcSEcCtD
Mupirocin—Hypersensitivity—Docetaxel—breast cancer	0.000454	0.000609	CcSEcCtD
Mupirocin—Cough—Epirubicin—breast cancer	0.000445	0.000596	CcSEcCtD
Mupirocin—Anaphylactic shock—Methotrexate—breast cancer	0.000444	0.000596	CcSEcCtD
Mupirocin—Hypersensitivity—Capecitabine—breast cancer	0.00044	0.00059	CcSEcCtD
Mupirocin—Pruritus—Docetaxel—breast cancer	0.000436	0.000585	CcSEcCtD
Mupirocin—Nausea—Paclitaxel—breast cancer	0.000432	0.000579	CcSEcCtD
Mupirocin—Skin disorder—Methotrexate—breast cancer	0.000432	0.000579	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000431	0.000578	CcSEcCtD
Mupirocin—Dry mouth—Epirubicin—breast cancer	0.000424	0.000569	CcSEcCtD
Mupirocin—Pruritus—Capecitabine—breast cancer	0.000422	0.000566	CcSEcCtD
Mupirocin—Diarrhoea—Docetaxel—breast cancer	0.000422	0.000565	CcSEcCtD
Mupirocin—Anaphylactic shock—Epirubicin—breast cancer	0.000416	0.000557	CcSEcCtD
Mupirocin—Cough—Doxorubicin—breast cancer	0.000411	0.000551	CcSEcCtD
Mupirocin—Diarrhoea—Capecitabine—breast cancer	0.000408	0.000547	CcSEcCtD
Mupirocin—Dizziness—Docetaxel—breast cancer	0.000408	0.000547	CcSEcCtD
Mupirocin—Skin disorder—Epirubicin—breast cancer	0.000404	0.000541	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000399	0.000534	CcSEcCtD
Mupirocin—Dizziness—Capecitabine—breast cancer	0.000395	0.000529	CcSEcCtD
Mupirocin—Dry mouth—Doxorubicin—breast cancer	0.000393	0.000526	CcSEcCtD
Mupirocin—Rash—Docetaxel—breast cancer	0.000389	0.000521	CcSEcCtD
Mupirocin—Dermatitis—Docetaxel—breast cancer	0.000388	0.000521	CcSEcCtD
Mupirocin—Headache—Docetaxel—breast cancer	0.000386	0.000518	CcSEcCtD
Mupirocin—Anaphylactic shock—Doxorubicin—breast cancer	0.000385	0.000516	CcSEcCtD
Mupirocin—Pain—Methotrexate—breast cancer	0.00038	0.000509	CcSEcCtD
Mupirocin—Rash—Capecitabine—breast cancer	0.000376	0.000505	CcSEcCtD
Mupirocin—Dermatitis—Capecitabine—breast cancer	0.000376	0.000504	CcSEcCtD
Mupirocin—Headache—Capecitabine—breast cancer	0.000374	0.000501	CcSEcCtD
Mupirocin—Skin disorder—Doxorubicin—breast cancer	0.000374	0.000501	CcSEcCtD
Mupirocin—Nausea—Docetaxel—breast cancer	0.000366	0.000491	CcSEcCtD
Mupirocin—Gastrointestinal pain—Methotrexate—breast cancer	0.000363	0.000487	CcSEcCtD
Mupirocin—Pain—Epirubicin—breast cancer	0.000356	0.000477	CcSEcCtD
Mupirocin—Nausea—Capecitabine—breast cancer	0.000355	0.000475	CcSEcCtD
Mupirocin—Urticaria—Methotrexate—breast cancer	0.000353	0.000473	CcSEcCtD
Mupirocin—Abdominal pain—Methotrexate—breast cancer	0.000351	0.000471	CcSEcCtD
Mupirocin—Gastrointestinal pain—Epirubicin—breast cancer	0.00034	0.000456	CcSEcCtD
Mupirocin—Urticaria—Epirubicin—breast cancer	0.00033	0.000443	CcSEcCtD
Mupirocin—Pain—Doxorubicin—breast cancer	0.000329	0.000441	CcSEcCtD
Mupirocin—Abdominal pain—Epirubicin—breast cancer	0.000329	0.000441	CcSEcCtD
Mupirocin—Hypersensitivity—Methotrexate—breast cancer	0.000327	0.000439	CcSEcCtD
Mupirocin—Gastrointestinal pain—Doxorubicin—breast cancer	0.000315	0.000422	CcSEcCtD
Mupirocin—Pruritus—Methotrexate—breast cancer	0.000314	0.000421	CcSEcCtD
Mupirocin—Hypersensitivity—Epirubicin—breast cancer	0.000306	0.000411	CcSEcCtD
Mupirocin—Urticaria—Doxorubicin—breast cancer	0.000306	0.00041	CcSEcCtD
Mupirocin—Abdominal pain—Doxorubicin—breast cancer	0.000304	0.000408	CcSEcCtD
Mupirocin—Diarrhoea—Methotrexate—breast cancer	0.000304	0.000408	CcSEcCtD
Mupirocin—Pruritus—Epirubicin—breast cancer	0.000294	0.000394	CcSEcCtD
Mupirocin—Dizziness—Methotrexate—breast cancer	0.000294	0.000394	CcSEcCtD
Mupirocin—Diarrhoea—Epirubicin—breast cancer	0.000285	0.000381	CcSEcCtD
Mupirocin—Hypersensitivity—Doxorubicin—breast cancer	0.000284	0.00038	CcSEcCtD
Mupirocin—Rash—Methotrexate—breast cancer	0.00028	0.000376	CcSEcCtD
Mupirocin—Dermatitis—Methotrexate—breast cancer	0.00028	0.000375	CcSEcCtD
Mupirocin—Headache—Methotrexate—breast cancer	0.000278	0.000373	CcSEcCtD
Mupirocin—Dizziness—Epirubicin—breast cancer	0.000275	0.000369	CcSEcCtD
Mupirocin—Pruritus—Doxorubicin—breast cancer	0.000272	0.000365	CcSEcCtD
Mupirocin—Nausea—Methotrexate—breast cancer	0.000264	0.000354	CcSEcCtD
Mupirocin—Diarrhoea—Doxorubicin—breast cancer	0.000263	0.000353	CcSEcCtD
Mupirocin—Rash—Epirubicin—breast cancer	0.000262	0.000351	CcSEcCtD
Mupirocin—Dermatitis—Epirubicin—breast cancer	0.000262	0.000351	CcSEcCtD
Mupirocin—Headache—Epirubicin—breast cancer	0.000261	0.000349	CcSEcCtD
Mupirocin—Dizziness—Doxorubicin—breast cancer	0.000254	0.000341	CcSEcCtD
Mupirocin—Nausea—Epirubicin—breast cancer	0.000247	0.000331	CcSEcCtD
Mupirocin—Rash—Doxorubicin—breast cancer	0.000243	0.000325	CcSEcCtD
Mupirocin—Dermatitis—Doxorubicin—breast cancer	0.000242	0.000325	CcSEcCtD
Mupirocin—Headache—Doxorubicin—breast cancer	0.000241	0.000323	CcSEcCtD
Mupirocin—Nausea—Doxorubicin—breast cancer	0.000229	0.000306	CcSEcCtD
